 CUPERTINO, Calif., Sept. 07, 2022 GLOBE NEWSWIRE -- Reviva Pharmaceuticals Holdings, Inc. NASDAQ: RVPH Reviva or the Company, a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system CNS, cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the H.C. Wainwright Global Investment Conference being held September 1214, 2022 and invites investors to participate via virtual one-on-one meetings or in-person in New York, NY. Please see additional details below: 